casp3

CASP3 Activator 1541B is an activator of the proenzyme forms of caspase-3, and is an inducer of cell death.

B-3852 is a Bradykinin inhibitor.

CASP3 Activator 1541 is an activator of the proenzyme forms of caspase-3, and induces cell death.

XIAP-CASP7 PPI-IN-1 is a reversible inhibitor of the XIAP:CASP7 interaction, effectively disrupting the connection between XIAP and CASP7. It selectively induces apoptosis in MCF-7 and caspase-3 low-expression (CASP3/DR) triple-negative breast cancer cells. The compound overcomes chemoresistance by down-regulating β-catenin and associated ABC transporters in paclitaxel-resistant MCF-7 cells. XIAP-CASP7 PPI-IN-1 is useful for breast cancer research.

Notoginsenoside R4 (Standard) is a reference standard for research and analysis in studies involving Notoginsenoside R4. Notoginsenoside R4 is a ginsenoside obtainable from ginseng roots and participates in molecular docking interactions with core disease-related targets including STAT3, AKT1, HRAS, VEGFA, and CASP3, demonstrating favorable binding affinity. These docking results of Notoginsenoside R4, complemented by visualization analyses, highlight Notoginsenoside R4 as an important functional constituent of Panax notoginseng saponins (PNS) with mechanistic implications for anticancer and pro-apoptotic signaling regulation.

Notoginsenoside R4 is a ginsenoside obtainable from ginseng roots and participates in molecular docking interactions with core disease-related targets including STAT3, AKT1, HRAS, VEGFA, and CASP3, demonstrating favorable binding affinity. These docking results of Notoginsenoside R4, complemented by visualization analyses, highlight Notoginsenoside R4 as an important functional constituent of Panax notoginseng saponins (PNS) with mechanistic implications for anticancer and pro-apoptotic signaling regulation.